Catalase immunoexpression in colorectal lesions
Open Access
- 1 January 2020
- journal article
- research article
- Published by Termedia Sp. z.o.o. in Gastroenterology Review
- Vol. 15 (4) , 330-337
Abstract
Introduction: It is generally accepted that the gastrointestinal tract, and especially the colon, is constantly exposed to reactive oxygen species (ROS) that may be responsible for the appearance of genetic mutations. To keep a steady-state control over ROS production-detoxification, organisms have evolved a defensive system. Nevertheless, many reports have described decreased level of antioxidant enzymes, especially catalase (CAT), in cancer tissues. Aim: In this work we try to assess the immunohistochemical expression of CAT protein in colorectal adenoma and adenocarcinoma samples. Material and methods: This study was performed on resected specimens obtained from 122 patients who had undergone surgical resection for colorectal cancer, and from 120 patients who had undergone colonoscopy. Paraffinembedded, 4 pm-thick tissue sections were stained for rabbit polyclonal anti CAT antibody obtained from GeneTex (cat. no. GTX110704). Results: In adenoma strong immunoexpression was detected mainly in infiltrating mononuclear cells within lamina propria. High expression of CAT was significantly associated with grade of dysplasia (high grade vs. low grade, p = 0.037). In adenocarcinoma samples, the high level of CAT immunoexpression was significantly correlated with histological grade of tumour (G1 vs. G2 vs. G3, p = 0.001) and depth of invasion (T1 vs. T2 vs. T3 vs. T4, p = 0.003). Conclusions: Development of colorectal cancer is associated with increased expression of CAT in the stage of adenoma and decreased expression in the stage of adenocarcinoma.Keywords
This publication has 35 references indexed in Scilit:
- Peroxisomal metabolism and oxidative stressBiochimie, 2014
- Downregulation of catalase by reactive oxygen species via hypermethylation of CpG island II on the catalase promoterFEBS Letters, 2010
- Influence of therapy on the antioxidant status in patients with melanomaJournal of Clinical Pharmacy and Therapeutics, 2008
- Oxyl radicals, redox-sensitive signalling cascades and antioxidantsCellular Signalling, 2007
- Free radicals and antioxidants in normal physiological functions and human diseaseThe International Journal of Biochemistry & Cell Biology, 2007
- Catalase reverses tumorigenicity in a malignant cell line by an epidermal growth factor receptor pathwayFree Radical Biology and Medicine, 2006
- Inhibition of experimental pulmonary metastasis by controlling biodistribution of catalase in miceInternational Journal of Cancer, 2002
- Expression and prognostic significance of catalase in malignant mesotheliomaCancer, 2001
- Oxidative DNA base damage and antioxidant enzyme activities in human lung cancerFEBS Letters, 1994
- Depression of catalase gene expression after immortalization and transformation of mouse liver cellsCarcinogenesis, 1993